Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening for ovarian cancer: a systematic review.

× No keyword cloud information.

9 in total

1. AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

Authors: Melissa K Brunckhorst; Dimitry Lerner; Shaomeng Wang; Qin Yu
Journal: Cancer Biol Ther Date: 2012-06-06 Impact factor: 4.742

2. Screening for ovarian cancer: recommendation statement.

Authors:
Journal: Ann Fam Med Date: 2004 May-Jun Impact factor: 5.166

3. Screening for coronary heart disease: cardiology through the oncology looking glass.

Authors: D Douglas Miller; Leslee J Shaw
Journal: J Nucl Cardiol Date: 2005 Mar-Apr Impact factor: 5.952

4. Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

Authors: Leslee J Shaw; Allen J Taylor; Patrick G O'Malley
Journal: Curr Treat Options Cardiovasc Med Date: 2005-08

5. Physician Nonprofessional Cancer Experience and Ovarian Cancer Screening Practices: Results from a National Survey of Primary Care Physicians.

Authors: Margaret Ragland; Katrina F Trivers; C Holly A Andrilla; Barbara Matthews; Jacqueline Miller; Denise Lishner; Barbara Goff; Laura-Mae Baldwin
Journal: J Womens Health (Larchmt) Date: 2018-08-10 Impact factor: 2.681

6. Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.

Authors: Iris L Romero; Ilyssa O Gordon; Sujatha Jagadeeswaran; Keeley L Mui; Woo Seok Lee; Daniela M Dinulescu; Thomas N Krausz; Helen H Kim; Melissa L Gilliam; Ernst Lengyel
Journal: Cancer Prev Res (Phila) Date: 2009-09-08

Screening for ovarian cancer: a systematic review.

1. AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

2. Screening for ovarian cancer: recommendation statement.

3. Screening for coronary heart disease: cardiology through the oncology looking glass.

4. Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

5. Physician Nonprofessional Cancer Experience and Ovarian Cancer Screening Practices: Results from a National Survey of Primary Care Physicians.

6. Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.

7. Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study.

Review 8. Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment.

Review 9. Does particulate air pollution contribute to infant death? A systematic review.